MAINTAINING MAXIMUM DOSAGE LIMITS FOR SYSTEMS FOR CONTROLLING THE INSULIN INJECTION WITH FEEDBACK Russian patent published in 2021 - IPC A61B5/145 

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, it can be used to control the insulin injection. A system for implementing the methods is proposed, wherein the system contains: a continuous glucose monitor, made with the possibility to provide the user's glucose levels at the same time intervals in the form of glucose measurement data; an insulin infusion pump, made with the possibility to inject insulin; and a controller functionally connected to an insulin infusion pump and a continuous glucose monitor. The controller is made with the possibility to predict at least one future glucose value based on previous glucose measurement data of the continuous glucose monitor, and determine the maximum insulin injection rate for the insulin infusion pump at the same time intervals based on: the basal insulin injection rate set by default at specified time intervals for a predetermined period of time and a temporary basal insulin injection rate, which is a temporary modification of the default basal insulin injection rate for a reduced period of time, and, optionally, the rate of additional bolus injection.

EFFECT: group of inventions provides an increase in the efficiency of controlling the insulin injection.

11 cl, 10 dwg